XML 40 R29.htm IDEA: XBRL DOCUMENT v3.8.0.1
Share-Based Compensation (Tables)
9 Months Ended
Sep. 30, 2017
Disclosure of Compensation Related Costs, Share-based Payments [Abstract]  
Summary of Stock Option Assumptions
The following weighted average assumptions were used to determine the fair value of the stock options granted on the original grant date for expense recognition purposes for options granted during the nine months ended September 30, 2017 and 2016 using a Black Scholes Model:
 
 
Nine months ended
 
September 30, 2017
 
September 30, 2016
Director and Officers:
 
 
 
Expected dividend rate
$
0.26

 
$
0.22

Expected volatility
30.81
%
 
42.38
%
Risk-free interest rate
1.90
%
 
2.02
%
Expected life (in years)
5.0

 
8.0

 
 
 
 
Employees:
 

 
 

Expected dividend rate
$
0.26

 
$
0.22

Expected volatility
30.70
%
 
40.41
%
Risk-free interest rate
1.88
%
 
1.60
%
Expected life (in years)
5.0

 
7.3

Summary of Stock Options Outstanding
The following is a summary of stock options vested and exercisable as of September 30, 2017:
 
Range of
Exercise
Prices
 
Number
of
Shares
 
Weighted
Average
Remaining
Contractual Life
(in years)
 
Weighted
Average
Exercise
Price
 
Intrinsic
Value
(in thousands)
$4.54-$22.76
 
374,792

 
4.61

 
$
10.96

 
$
4,209

$23.57-$32.80
 
41,490

 
7.86

 
25.61

 
18

$32.85-$37.30
 

 

 

 

Total
 
416,282

 
4.93

 
$
12.42

 
$
4,227

 
The following is a summary of stock options vested and exercisable as of September 30, 2016:

Range of
Exercise
Prices
 
Number
of
Shares
 
Weighted
Average
Remaining
Contractual Life
(in years)
 
Weighted
Average
Exercise
Price
 
Intrinsic
Value
(in thousands)
$4.54-$8.65
 
329,433

 
4.79
 
$
7.62

 
$
6,984

$8.70-$22.76
 
38,598

 
7.01
 
15.09

 
530

$23.57-$28.27
 
7,764

 
8.31
 
23.61

 
40

Total
 
375,795

 
5.09
 
$
8.72

 
$
7,554

Summary of Stock Option Activity
A summary of option activity under the plans is as follows:

Options
Shares
 
Weighted
Average
Exercise
Price
Outstanding at December 31, 2016
1,450,704

 
$
21.33

Granted
403,260

 
34.43

Exercised
(165,876
)
 
10.34

Forfeited or Expired
(85,326
)
 
30.63

Outstanding at September 30, 2017
1,602,762

 
$
25.27

Exercisable at September 30, 2017
416,282

 
$
12.42

Summary of Unvested Restricted Stock Awards
A summary of the unvested restricted stock awards is as follows:
 
Restricted stock
Shares
 
Weighted
Average
Grant Date
Fair Value
Unvested at December 31, 2016
408,162

 
$
20.47

Granted
123,151

 
33.96

Vested
(133,729
)
 
20.23

Forfeited
(20,054
)
 
22.09

Unvested at September 30, 2017
377,530

 
$
24.87

Summary of Grant Date Fair Value of Awards During Period
A summary of share-based compensation is as follows:
 
 
Three months ended
 
Nine months ended
 
September 30,
2017
 
September 30,
2016
 
September 30,
2017
 
September 30,
2016
Grant date fair value of awards during the period:
(in thousands)
Options
$
121

 
$
360

 
$
3,628

 
$
2,419

Restricted stock

 
67

 
4,182

 
3,009

Total
$
121

 
$
427

 
$
7,810

 
$
5,428

Summary of Share-Based Compensation Expense
Share-based compensation expense:
 
 
 
 
 
 
 
Options
$
620

 
$
457

 
$
2,050

 
$
1,198

Restricted stock
811

 
672

 
2,910

 
1,974

Total
$
1,431

 
$
1,129

 
$
4,960

 
$
3,172

Summary of Income Tax Benefit Related to Share-Based Compensation
Income tax benefit/(deficiency) related to share-based compensation:
 
 
 
 
 
 
 
Options
$
126

 
$
311

 
$
1,411

 
$
1,441

Restricted stock
131

 
326

 
836

 
325

Total
$
257

 
$
637

 
$
2,247

 
$
1,766